Gelonghui October 30th | Lionco Pharmaceutical Group (603669.SH) released its third-quarter report, with revenue of 0.231 billion yuan in the first three quarters, a year-on-year increase of 53.34%, a net loss of 46.8899 million yuan, a non-GAAP net loss of 90.86 million yuan, and basic earnings per share of -0.07 yuan.
灵康药业(603669.SH)：前三季净亏损4688.99万元
lionco pharmaceutical group (603669.SH): a net loss of 46.8899 million yuan in the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated